Sidoti Csr Has Pessimistic Outlook of SBC FY2024 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Analysts at Sidoti Csr reduced their FY2024 EPS estimates for SBC Medical Group in a research report issued to clients and investors on Wednesday, March 26th. Sidoti Csr analyst A. Shah now anticipates that the company will post earnings of $0.57 per share for the year, down from their previous forecast of $0.58. The consensus estimate for SBC Medical Group’s current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group’s Q1 2025 earnings at $0.16 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.64 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.18 EPS, Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.19 EPS and FY2026 earnings at $0.71 EPS.

SBC Medical Group Price Performance

NASDAQ:SBC opened at $3.28 on Thursday. The business’s 50 day moving average price is $4.41. SBC Medical Group has a 1-year low of $2.62 and a 1-year high of $12.50. The company has a quick ratio of 2.76, a current ratio of 2.79 and a debt-to-equity ratio of 0.06.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.